{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:51:31Z","timestamp":1740135091059,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI095041"],"award-info":[{"award-number":["R01AI095041"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3088-8","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T12:36:44Z","timestamp":1523882204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Deanna","family":"Kerrigan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Tudor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katlego","family":"Motlhaoleng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limakatso","family":"Lebina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cokiswa","family":"Qomfu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Variava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"3088_CR1","unstructured":"World Health Organization (WHO). Global tuberculosis report; 2017. \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259366\/9789241565516-eng.pdf?sequence=1\n                    \n                  . Accessed 11 Oct 2017."},{"key":"3088_CR2","doi-asserted-by":"publisher","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010:CD000171. \n                    https:\/\/doi.org\/10.1002\/14651858.CD000171.pub3\n                    \n                  .","DOI":"10.1002\/14651858.CD000171.pub3"},{"key":"3088_CR3","volume-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings","author":"World Health Organization (WHO)","year":"2011","unstructured":"World Health Organization (WHO). Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. 2011. \n                    http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241500708_eng.pdf\n                    \n                  . Accessed 11 Apr 2017."},{"key":"3088_CR4","unstructured":"Department of Health, Republic of South Africa. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. 2015. \n                    https:\/\/www.scribd.com\/doc\/268965647\/National-Consolidated-Guidelines-for-PMTCT-and-the-Management-of-HIV-in-Children-Adolescents-and-Adults\n                    \n                  . Accessed 11 Apr 2017."},{"key":"3088_CR5","volume-title":"Latent tuberculosis infection: a guide for primary health care providers","author":"Centers for Disease Control and Prevention (CDC)","year":"2016","unstructured":"Centers for Disease Control and Prevention (CDC). Latent tuberculosis infection: a guide for primary health care providers. 2016. \n                    http:\/\/www.cdc.gov\/tb\/publications\/ltbi\/\n                    \n                  . Accessed 11 Apr 2017."},{"key":"3088_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/506432","volume":"43","author":"FG Cobelens","year":"2006","unstructured":"Cobelens FG, Egwaga SM, van Ginkel T, Muwinge H, Matee MI, Borgdorff MW. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. Clin Infect Dis. 2006;43:634\u20139. \n                    https:\/\/doi.org\/10.1086\/506432\n                    \n                  .","journal-title":"Clin Infect Dis"},{"key":"3088_CR7","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1097\/QAI.0000000000000895","volume":"71","author":"H Huerga","year":"2016","unstructured":"Huerga H, Mueller Y, Ferlazzo G, Mpala Q, Bevilacqua P, Vasquez B, et al. Implementation and operational research: feasibility of using tuberculin skin test screening for initiation of 36-month isoniazid preventive therapy in HIV-infected patients in resource-constrained settings. J Acquir Immune Defic Syndr. 2016;71:e89\u201395. \n                    https:\/\/doi.org\/10.1097\/QAI.0000000000000895\n                    \n                  .","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3088_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.eimc.2009.05.012","volume":"28","author":"A Llvani","year":"2010","unstructured":"Llvani A, Pareek M. Interferon gamma release assays: principles and practice. Enfermedades Infecciosas y Microbiolog\u00eda Clin\u00edca. 2010;28:245\u201352.","journal-title":"Enfermedades Infecciosas y Microbiolog\u00eda Clin\u00edca"},{"key":"3088_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","volume":"27","author":"M Pai","year":"2014","unstructured":"Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27:3\u201320. \n                    https:\/\/doi.org\/10.1128\/CMR.00034-13\n                    \n                  .","journal-title":"Clin Microbiol Rev"},{"key":"3088_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2466-10-7","volume":"10","author":"A Pooran","year":"2010","unstructured":"Pooran A, Booth H, Miller RF, Scott G, Badri M, Huggett JF, Dheda K. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulmonary Medicine. 2010;10:7. \n                    https:\/\/doi.org\/10.1186\/1471-2466-10-7\n                    \n                  .","journal-title":"BMC Pulmonary Medicine"},{"key":"3088_CR11","volume-title":"Qualitative inquiry and research design: choosing among five traditions","author":"JW Creswell","year":"1998","unstructured":"Creswell JW. Qualitative inquiry and research design: choosing among five traditions. Thousand Oaks, CA: Sage Publications; 1998."},{"issue":"6","key":"3088_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. \n                    https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"Int J Qual Health Care"},{"key":"3088_CR13","volume-title":"Transforming qualitative information: thematic analysis and code development","author":"RE Boyatzis","year":"1998","unstructured":"Boyatzis RE. Transforming qualitative information: thematic analysis and code development. Thousand Oaks, London & New Dehli: SAGE Publications; 1998."},{"key":"3088_CR14","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0140-6736(04)16987-0","volume":"364","author":"P Travis","year":"2004","unstructured":"Travis P, Bennett S, Haines A, Pang T, Bhutta Z, Hyder AA, Evans T. Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet. 2004;364:900\u20136. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(04)16987-0\n                    \n                  .","journal-title":"Lancet"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3088-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:45:57Z","timestamp":1589539557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3088-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3088"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3088-8","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2018,4,16]]},"assertion":[{"value":"3 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Boards of the Johns Hopkins School of Medicine and the University of Witwatersrand in South Africa approved this study. All participants provided written consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors provide their consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"288"}}